MENU
KALV
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
KalVista Pharmaceuticals (KALV) Ownership - Who owns KalVista Pharmaceuticals?
KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases... Show more
Industry: #Pharmaceuticals Other
Profile
Industry
Pharmaceuticals Other
Address
55 Cambridge Parkway
Phone
+1 857 999-0075
Employees
118
Web
https://www.kalvista.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
562.78M
P/E Ratio
N/A
Total Cash
253.2M
Projected Growth
N/A
Total Debt
5.78M
Revenue
N/A
Risk (Beta)
-0.16
Dividend Yield
N/A
Total Cash/Share
5.09
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
KALV
Capitalization
563M
P/E Ratio
N/A
Risk (Beta)
-0.16
Dividend Yield
N/A
Total Cash
253M
Total Cash/Share
5.09
Total Debt
5.78M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
145M
P/B Ratio
3.80
Cash Flow
N/A
Earnings
-3.77
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
49K
Current Ratio
10.44
Current Revenue Per Employee
68285.71
Dividends Per Share - Security
N/A
EBITDA
-173.23M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-90.20
Shares Held By Institutions
562M
Shares Outstanding - Current
49.7M
Total Liabilities
131M
Total Volume MTD
N/A
Value
N/A
Gain YTD
30.933
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of pharmaceuticals
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
55 Cambridge Parkway
Phone
+1 857 999-0075
Employees
118
Web
https://www.kalvista.com